fingolimod
ItalyDrugs containing this active substance
-
It is used for the treatment of relapsing-remitting multiple sclerosis (RRMS) in adults and children/adolescents (from 10 years of age onwards), particularly for those who have not responded to other therapies or for those with a severe, rapidly progressing form. It does not cure the disease, but it helps to reduce relapses and slow the progression of physical disability.
Form: capsules, hard gelatin
Active substance Dosage fingolimod - ATC: L04AE01
Manufacturer: ACCORD HEALTHCARE, S.L.U.
-
It is used in adults, adolescents, and children from 10 years of age (weighing more than 40 kg) for the treatment of relapsing-remitting multiple sclerosis (RRMS), particularly for those who have not responded to other therapies or for those with a severe, rapidly progressing form. It does not cure the disease, but it helps to reduce relapses and slow the progression of physical disability.
Form: capsules, hard gelatin
Active substance Dosage fingolimod - ATC: L04AE01
Manufacturer: EG S.P.A.
-
It is used in adults and children and adolescents (from 10 years of age and older) for the treatment of relapsing-remitting multiple sclerosis (RRMS), particularly for patients who have not responded to other therapies or for those with a severe, rapidly progressing form. It does not cure the disease, but it helps to reduce relapses and slow the progression of physical disability.
Form: capsules, hard gelatin
Active substance Dosage fingolimod - ATC: L04AE01
Manufacturer: HCS BV
-
It is used for the treatment of relapsing-remitting multiple sclerosis (RRMS) in adults and children and adolescents aged 10 years and older, particularly for those who have not responded to other therapies or for those with a severe, rapidly progressing form. It helps to reduce relapses and slow the progression of physical disability.
Form: capsules, hard gelatin
Active substance Dosage fingolimod - ATC: L04AE01
Manufacturer: TILLOMED ITALIA SRL
-
Gilenya is used in adults and children and adolescents (from 10 years of age and older) to treat relapsing-remitting multiple sclerosis (RRMS), particularly for patients who have not responded to other therapies or who have a severe, rapidly progressing form. The drug helps to reduce the number of relapses and slow the progression of physical disability.
Form: capsules, hard gelatin
Active substance Dosage fingolimod - ATC: L04AE01
Manufacturer: NOVARTIS EUROPHARM LIMITED